Exploring COVID-19 Therapies: An Extraordinary Global Challenge.
作者信息
Mohta Srikant, Agarwal Ashish, Makharia Govind K
机构信息
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
出版信息
J Dig Endosc. 2020 Mar;11(1):73-75. doi: 10.1055/s-0040-1712598. Epub 2020 May 16.
Abstract
摘要
相似文献
1
Exploring COVID-19 Therapies: An Extraordinary Global Challenge.探索新冠病毒治疗方法：一项艰巨的全球挑战。
J Dig Endosc. 2020 Mar;11(1):73-75. doi: 10.1055/s-0040-1712598. Epub 2020 May 16.
2
Extraordinary challenge, extraordinary achievement: 2020-2021 year in review.非凡挑战，非凡成就：2020 - 2021年回顾
Stem Cell Reports. 2021 Jun 8;16(6):1391-1393. doi: 10.1016/j.stemcr.2021.05.015.
3
Deriving happiness through extraordinary or ordinary brand experiences in times of COVID-19 threat.在新冠疫情威胁时期，通过非凡或普通的品牌体验获得幸福。
J Consum Aff. 2022 Jun 30. doi: 10.1111/joca.12465.
4
A COVID-19 vaccine-dare to dream.一种新冠疫苗——敢于梦想。
Br J Community Nurs. 2020 Dec 2;25(12):2-7. doi: 10.12968/bjcn.2020.25.12.598.
5
The role of Big Data in the business challenge of Covid-19: a systematic literature review in managerial studies.大数据在新冠疫情商业挑战中的作用：管理研究的系统文献综述
Procedia Comput Sci. 2022;200:1746-1755. doi: 10.1016/j.procs.2022.01.375. Epub 2022 Mar 8.
6
COVID-19 human challenge studies: ethical issues.COVID-19 人体挑战研究：伦理问题。
Lancet Infect Dis. 2020 Aug;20(8):e198-e203. doi: 10.1016/S1473-3099(20)30438-2. Epub 2020 May 29.
7
Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies.新冠疫情期间抑郁症的患病率：基于社区研究的荟萃分析
Int J Clin Health Psychol. 2021 Jan-Apr;21(1):100196. doi: 10.1016/j.ijchp.2020.07.007. Epub 2020 Aug 31.
8
Exploring the Impact of COVID-19 on Progress Towards Achieving Global Surgery Goals.探讨 COVID-19 对实现全球外科目标进展的影响。
World J Surg. 2020 Aug;44(8):2451-2457. doi: 10.1007/s00268-020-05627-7.
9
Mobilizing COVID-19 level public health interventions for climate breakdown is necessary.调动应对新冠疫情级别的公共卫生干预措施来应对气候崩溃是必要的。
J Clim Chang Health. 2022 Oct;8:100152. doi: 10.1016/j.joclim.2022.100152. Epub 2022 Jun 24.
10
An Ounce of Prevention: Coronavirus (COVID-19) and Mass Gatherings.预防为主：冠状病毒（COVID-19）与大规模集会
Cureus. 2020 Mar 20;12(3):e7345. doi: 10.7759/cureus.7345.
本文引用的文献
1
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
2
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
3
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
4
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
5
Pathogenesis of COVID-19 from a cell biology perspective.从细胞生物学角度看 COVID-19 的发病机制。
Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.00607-2020. Print 2020 Apr.
6
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.氯喹和羟氯喹在治疗伴有或不伴有糖尿病的2019冠状病毒病中的应用：一项系统检索及叙述性综述，特别提及印度和其他发展中国家
Diabetes Metab Syndr. 2020 May-Jun;14(3):241-246. doi: 10.1016/j.dsx.2020.03.011. Epub 2020 Mar 26.
7
Estimates of the severity of coronavirus disease 2019: a model-based analysis.新型冠状病毒疾病 2019 严重程度的估计：基于模型的分析。
Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30.
8
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.利巴韦林治疗新型冠状病毒：COVID-19 评估的基础。
J Med Virol. 2020 Jul;92(7):740-746. doi: 10.1002/jmv.25798. Epub 2020 Apr 10.
9
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动：2019 冠状病毒病（COVID-19）危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
10
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
Zotero 插件